You are here: Industry Insights > favipiravir

News List

Lupin launches generic favipiravir, Covihalt to treat coronavirus infection expresspharma
August 06, 2020
Lupin’s Covihalt is available as 200 mg tablets in the form of a strip of 10 tablets and priced at Rs 49 per tablet.
Alkem launches favipiravir under brand name Alfluenza expresspharma
August 06, 2020
Favipiravir is approved by the DCGI restricted emergency use in India for the treatment of mild to moderate cases of COVID-19.
Sun Pharma launches generic favipiravir, FluGuard at Rs 35 per tablet expresspharma
August 05, 2020
Sun Pharmaceutical Industries has launched FluGuard (Favipiravir 200 mg) at a price of Rs 35 per tablet, for the treatment of mild to moderate cases of COVID-19 in India.
Remdesivir and favipiravir price regulation required to safeguard patients’ interest in India: GlobalData expresspharma
August 04, 2020
Both drugs have seen a sharp decline in price since the availability of the first generic in India.
Hetero launches generic favipiravir to treat Covid-19 in India pharmaceutical-technology
July 31, 2020
India-based Hetero Labs has launched a generic version of antiviral drug favipiravir, under the brand name Favivir, to treat Covid-19 patients in the country.
Hetero launches Favivir to treat mild to moderate Covid-19 expresspharma
July 30, 2020
Favivir, priced at Rs 59 per tablet, will be available at all retail medical outlets and hospital pharmacies across the country but will be sold only on prescription.
Avra Laboratories gets CDSCO nod for favipiravir API expresspharma
July 29, 2020
The company informed that it is now supplying commercial quantities to Cipla for the launch of Ciplenza.
CSIR-IICT develops cost effective process technology for Favipiravir expresspharma
July 27, 2020
The research lab announced that its had transferred the technology to Cipla, which has recently DCGI for permission to launch the COVID-19 treatment in India.
Jenburkt Pharmaceuticals second in India to launch Favipiravir (FaviventTM) to fight COVID-19 expresspharma
July 27, 2020
Favipiravir is a broad spectrum anti-viral agent and selectively inhibits RNA polymerase of influenza virus and prevents viral replication.
Brinton Pharmaceuticals gets DCGI’s approval to launch favipiravir anti-viral tablets in India expresspharma
July 24, 2020
Brinton Pharmaceuticals has received approval from Drugs Controller General of India (DCGI) to market favipiravir under the brand name faviton.

Previous page 1 2 3 4 5 6 Next page